This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Lifevantage Corporation
11/9/2026
Thank you for standing by. Welcome to today's conference call to discuss LifeVantage's first quarter fiscal year 2027 results. At this time, all participants are in a listen-only mode. Following the formal remarks, we will conduct a question and answer session. Instructions will be provided at that time for you to queue up. Hosting today's conference will be Reed Anderson with ICR. As a reminder, today's conference is being recorded. and now I would like to turn the conference over to Mr. Anderson. Please go ahead.
Thank you and good afternoon everyone and welcome to LifeVantage Corporation's conference call to discuss results for the quarter end of September 30th, 2026. On the call today from LifeVantage are Terrence Moorhead, President and Chief Executive Officer and Carl Aure, Chief Financial Officer. By now everyone should have access to the earnings release which went out this afternoon at approximately 4 or 5 p.m. Eastern Time. If you have not received this release, it is available on the investor relations portion of LifeVantage's website at www.lifevantage.com. This call is being webcast and a replay will be available on the company's website as well. Before we begin, we'd like to remind everyone that our prepared remarks contain folder-looking statements and management may make additional folder-looking statements in response to your questions. These statements do not guarantee future performance and therefore undue reliance should not be placed upon them. These statements are based on the current expectations of the company's management and involve inherent risks and uncertainties including those identified in the risk factors section of LifeVantage's most recently filed forms 10-K and 10-Q. Please note that during today's call we will discuss non-GAAP financial measures including results on an adjusted basis. Management believes these financial measures can facilitate a more complete analysis and greater transparency into LifeVantage's ongoing results of operations Thank you, Reed, and good afternoon, everyone.
Today, I'm going to walk you through some of the initial progress we've made and provide a brief outline of our plans moving forward. Carl's going to walk you through our first quarter performance and financials in a few minutes, but I want to use my time today to focus primarily on where we go from here. I've been with LifeVantage for just over 90 days, and during that time, I've taken the opportunity to listen, learn, and work with our consultants, consumers, employees, and boards. I joined the company believing LifeVantage had far greater potential than its current scale reflects. And after a comprehensive review of the business, I believe that even more strongly today. But we have a lot of work to do. In the first quarter, our sales saw revenue decline 22% to $37.1 million. And adjusted EBITDA was $1.9 million. The decline was driven by a decrease in both orders and Average Order, which reinforces our belief that we need to pursue meaningful change, the type of change that we're committed to delivering. Fortunately, we're moving forward from a position of financial stability. We ended the first quarter with $13.7 million in cash, no debt, and positive operating cash flow. We also benefit from strong gross margins, a unique and highly differentiated product line, and the foundation of subscription-based accounts. On our last call, I outlined three priorities needing attention. The brand, our consumer proposition and operational excellence and productivity. Over the past 90 days, we've dug deeper and have concluded that we need a comprehensive strategy that reimagines our go-to-market approach, our marketing engine, our competitive Our brand lies at the heart of the transformation. There are thousands of supplement companies essentially selling the same products with the same ingredients and the same benefits to the same consumers. Some offer different forms and features, but beyond their marketing campaigns, many are virtually indistinguishable. LifeVantage, on the other hand, can occupy a much more distinctive space. That's because LifeVantage is built around a fundamentally different proposition. Rather than simply giving the body more ingredients, more products, and more things to take, we develop products designed to work with the body's own biology and activate natural processes that are clinically proven to improve people's health. That distinction lies at the heart of what differentiates LifeVantage, and it positions the company in a new, growing, and ownable white space as the next generation of health and science. Of course, the challenge is to take our differentiated approach to health and science and turn it into a differentiated consumer proposition and ultimately a differentiated brand. That's the starting point of our strategic roadmap, which has three major components. The first strategic building block focuses on repositioning the company to change the way people think about life advantage and to give consumers a reason to care about the brand. That means repositioning LifeVantage as a next generation nutraceutical company. That positioning builds on our product's unique ability to activate the body's powerful biological systems to improve people's health. To get started, we're launching a new campaign based on groundbreaking new research that shows how our lead product Protandim NRF2 Activates the body's natural defense system to protect the body from environmental toxins like microplastics, pesticides, pollution, and more. For the first time, the new campaign uses before and after images that show the positive impact protandim has on cells affected by specific environmental toxins. It's an exciting new approach designed to create emotional connection with the brand. We start with an important consumer outcome, which in this case is to protect the body from environmental toxins, and we follow up with simple-to-understand visuals that provide scientific proof. Our second strategic building block focuses on reimagining the business proposition to make it easier to discover, engage with, and share life advantage. Our approach is to modernize the business, build new capabilities, and align with the way consumers shop and buy today. To be clear, we're focusing on rethinking the selling proposition to make it simpler, more digital and more attractive while at the same time reimagining the consumer journey to strengthen acquisition, retention, referrals and social engagement. In the second quarter of calendar year 2027, we'll launch our new website and a more modern digital platform in North America, followed by a third quarter 2020-27 launch of a new consumer-driven business suite for sellers. Our goal is to combine the reach and convenience of an integrated digital ecosystem with the affinity that comes from a community capable of driving engagement around the brand. Our third strategic building block focuses on expanding beyond our current scale in scope to more aggressively penetrate key markets, expand share in high potential categories, and identify new growth platforms. I'm not going to discuss details here to preserve our strategic interests. However, the overriding principle is focus. We need to become more selective about where we compete and where we invest. I want to be thoughtful about expectations. It's still early, but we realize we need to reset the economics of the business by creating a more focused, tighter organization with improved efficiency. That work is progressing, so I'm not going to get ahead of myself, and we're not providing formal guidance today. But shareholders should understand that our transformation agenda addresses both sides of the value creation equation. Finally, before turning the call over to Carl to cover Q1 Financials, I want to touch on an additional item that will help our ability to build momentum and strength as we execute our strategy. Starting January 1, 2027, our fiscal year will align with the calendar year. That means we'll have one calendar for strategy, planning, budgeting, incentives, innovation, commercial activation, and performance management. It's a relatively simple change with significant implications for how we run the company. And the timing is appropriate as January 1st marks the beginning of the next generation of the company that we're building. With that, I'd like to turn the call over to Carl so he can walk you through our financial results in more detail. Carl?
You're reading a preview of the LFVN Q1 2027 earnings call.
Free account.
Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.
Use this data in your own app
Pull this call's transcript, audio and slides with the Earnings call transcripts API.
See pricing